VANIQA (pronounced "VAN-i-ka") is a prescription
medication applied to the skin for the reduction of unwanted
facial hair in women. VANIQA is the first prescription therapy
cream which has been approved by the FDA to eliminate unwanted
facial hair growth. Heralded as a revolutionary new product
for women, VANIQA is a breakthrough in the field of dermatology.
VANIQA interferes with an enzyme found in the hair follicle
of the skin needed for hair growth. This in turn results
in slower hair growth and improved appearance where VANIQA
is applied. Application of VANIQA does not permanently remove
hair or "cure" unwanted facial hair. It is not
a depilatory. Women wishing to use VANIQA should initially
continue to use their current hair removal technique(s).
Proper usage of VANIQA will help patients manage their condition
and improve their appearance.
With the aid of VANIQA Improvement in the condition of unwanted
facial hair growth will occur gradually. Women using VANIQA
should not be discouraged if they see no immediate improvement.
Changes to facial hair may be seen as early as 4 to 8 weeks.
It should be noted that improvement may take longer in some
individuals. If no improvement is seen after 6 months of
use, discontinue use.
Empresa
